Monday, December 12, 2022

Experimental cancer therapy shows success in more than 70% of patients in global clinical trials

A new therapy that makes the immune system kill bone marrow cancer cells was successful in as many as 73 percent of patients in two clinical trials.

from Top Health News -- ScienceDaily https://ift.tt/fMlR45U
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

A protein older than blood circulation could transform cancer immunotherapy

A protein that evolved long before the human circulatory system may help unlock stronger cancer treatments. When C3 is produced inside tumor...